Elaine Symanski1, Katherine B Ensor2, Pedro A Piedra3,4, Komal Sheth5, Kelsey Caton5, Stephen L Williams5, David Persse5,6, Deborah Banerjee5, Loren Hopkins2,5. 1. Center for Precision Environmental Health, Department of Medicine, Section of Epidemiology and Population Sciences, Baylor College of Medicine, Houston, Texas, USA. 2. Department of Statistics, Rice University, Houston, Texas, USA. 3. Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas, USA. 4. Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA. 5. Houston Health Department, Houston, Texas, USA. 6. Departments of Emergency Medicine and Surgery, Baylor College of Medicine, Houston, Texas, USA.
Abstract
BACKGROUND: In contrast to studies that relied on volunteers or convenience sampling, there are few population-based severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroprevalence investigations and most were conducted early in the pandemic. The health department of the fourth largest US city recognized that sound estimates of viral impact were needed to inform decision making. METHODS: Adapting standardized disaster research methodology, in September 2020 the city was divided into high and low strata based on reverse-transcriptase polymerase chain reaction (RT-PCR) positivity rates; census block groups within each stratum were randomly selected with probability proportional to size, followed by random selection of households within each group. Using 2 immunoassays, the proportion of infected individuals was estimated for the city, by positivity rate and sociodemographic and other characteristics. The degree of underascertainment of seroprevalence was estimated based on RT-PCR-positive cases. RESULTS: Seroprevalence was estimated to be 14% with near 2-fold difference in areas with high (18%) versus low (10%) RT-PCR positivity rates and was 4 times higher compared to case-based surveillance data. CONCLUSIONS: Seroprevalence was higher than previously reported and greater than estimated from RT-PCR data. Results will be used to inform public health decisions about testing, outreach, and vaccine rollout.
BACKGROUND: In contrast to studies that relied on volunteers or convenience sampling, there are few population-based severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroprevalence investigations and most were conducted early in the pandemic. The health department of the fourth largest US city recognized that sound estimates of viral impact were needed to inform decision making. METHODS: Adapting standardized disaster research methodology, in September 2020 the city was divided into high and low strata based on reverse-transcriptase polymerase chain reaction (RT-PCR) positivity rates; census block groups within each stratum were randomly selected with probability proportional to size, followed by random selection of households within each group. Using 2 immunoassays, the proportion of infected individuals was estimated for the city, by positivity rate and sociodemographic and other characteristics. The degree of underascertainment of seroprevalence was estimated based on RT-PCR-positive cases. RESULTS: Seroprevalence was estimated to be 14% with near 2-fold difference in areas with high (18%) versus low (10%) RT-PCR positivity rates and was 4 times higher compared to case-based surveillance data. CONCLUSIONS: Seroprevalence was higher than previously reported and greater than estimated from RT-PCR data. Results will be used to inform public health decisions about testing, outreach, and vaccine rollout.
Authors: Cesar A Lopez; Clark H Cunningham; Sierra Pugh; Katerina Brandt; Usaphea P Vanna; Matthew J Delacruz; Quique Guerra; D Ryan Bhowmik; Samuel J Goldstein; Yixuan J Hou; Margaret Gearhart; Christine Wiethorn; Candace Pope; Carolyn Amditis; Kathryn Pruitt; Cinthia Newberry-Dillon; John L Schmitz; Lakshmanane Premkumar; Adaora A Adimora; Ralph S Baric; Michael Emch; Ross M Boyce; Allison E Aiello; Bailey K Fosdick; Daniel B Larremore; Aravinda M de Silva; Jonathan J Juliano; Alena J Markmann Journal: mSphere Date: 2022-05-19 Impact factor: 5.029
Authors: Joshua L Kennedy; J Craig Forrest; Sean G Young; Benjamin Amick; Mark Williams; Laura James; Jessica Snowden; Victor M Cardenas; Danielle Boothe; Catherine Kirkpatrick; Zeel Modi; Katherine Caid; Shana Owens; Marianne Kouassi; Ryan Mann; Claire Putt; Katherine Irish-Clardy; Michael Macechko; Ronald K Brimberry; Wendy N Nembhard; Pearl A McElfish; Ruofei Du; Jing Jin; Namvar Zohoori; Atul Kothari; Hoda Hagrass; Ericka Olgaard; Karl W Boehme Journal: Open Forum Infect Dis Date: 2022-03-23 Impact factor: 4.423
Authors: Rashida Callender; Joally M Canales; Carolina Avendano; Elena Craft; Katherine B Ensor; Marie Lynn Miranda Journal: Environ Res Date: 2022-08-07 Impact factor: 8.431